Summary We have investigated the secretion of interferon a (IFN-a). IFN-y, interleukin-1 a (IL-1a), IL-15, IL-2 and tumour necrosis factor a (TNF-a) in whole blood cell cultures (WBCCs) of colorectal cancer patients upon mitogen stimulation. Whereas the values for IL-1i and TNFa remained virtually unchanged in comparison with healthy control subjects, WBCCs of colorectal cancer patients secreted significantty lower amounts of IFN-a (P < 0.005), IFN-y(P < 0.0001), IL-1 a (P < 0.0001) and IL-2 (P < 0.05). This reduction correlated with the progression of the disease. The total leucocyte and monocyte population were almost identical in both groups. In contrast. a dramatic depletion of lymphocytes was observed in colorectal cancer patients, which affected both lymphocyte counts (P < 0.0005) and their distribution (P < 0.0001). Our results suggest a selective suppression of cytokines in colorectal cancer patients that is related to tumour burden. Several mechanisms might account for this phenomenon. one of which might be lymphocyte depletion. al. 1990 al. : Fischer et al. 1994 ). We recentl1 show-ed that a decrease in IL-2 production in whole blood cell cultures (WBCCs) is correlated with a poor survixal rate in small-cell lung cancer patients (Fischer et al. 1997). underlining the importance of an exactlv balanced equilibrium of cvtokine concentrations.
Patients sufferinn from solid tumours frequently show a depressed function of their immunocompetent cells. Such immunodeficiencies haxe been reported in patients with different types of carcinoma. including colorectal cancer (Wanebo et al. 1980 : Bodmer et al. 1989 : Yoshino et al. 1992 : O'Sullixan et al. 1996 .
Soluble cvtokines are important regulatory molecules of numerous immune responses. The measurement of cvtokine production might. therefore. be a helpful parameter to assess the immunological competence of tumour patients. Sexeral groups.
including our ow-n. have reported selective changes in the cvtokine profile secreted by lymphocytes and monocytes of carcinoma patients (Rev et al. 1983 : Elsasser-Beile et al. 1993a .b: Fischer et al. 1995 : De Groote et al. 1996 . Such a reduction might at least in part occur as a consequence of soluble immunosuppressix e factors that are released bv tumour cells (Ebert et al. 1990 : Fischer et al. 1994 ). We recentl1 show-ed that a decrease in IL-2 production in whole blood cell cultures (WBCCs) is correlated with a poor survixal rate in small-cell lung cancer patients (Fischer et al. 1997) . underlining the importance of an exactlv balanced equilibrium of cvtokine concentrations.
In the present report wxe inx estigated cx tokine secretion bv peripheral leucocytes in patients w ith colorectal cancer. We provide exidence that the lexels of IFN-a. IFN-y. IL-1 a and IL-2 are selectixelv reduced in colorectal cancer patients compared w ith healthy control subjects. In addition. w e hax e obserxed sexere alterations in the lymphocyte compartment of the carcinoma patients. 
MATERIALS AND METHODS Patients
Blood samples were tak-en from -4 healthy x olunteers (mean age 52 years. range 29-62) and from 28 patients (17 male. 11 female) wxith histologicallv confirmed colorectal carcinoma (mean age 67 -ears. range 40-82). In 13 patients early stages w ere diacnosed (Dukes' A and B). whereas 15 showxed progressed stages of colorectal carcinoma (Dukes' C and D). None of the patients had receixed chemoor radiotherapy before the time wxhen blood w as taken.
Reagents
Phvtohaemagglutinin-M (PHA xxas purchased from 'Wellcome (Reinach. Sw itzerland ). The Newxcastle disease X irus (NDV) preparation xas kindly proxvided by Dr R Zawatzky (Gernan Cancer Research Center. Heidelberg. Germany).
Blood samples
Heparinized blood (20 ml) w as tak-en between 08.00 and 11.00 h from healthyx volunteers or cancer patients and used wxithin 3 h for further investigations. In parallel. total and differential leucocyte counts x ere determined automatically from the same xenous puncture.
Whole blood cell culture and stimulation of cytokine secretion Heparinized blood xxas diluted 1:5 in RPMI-1640 (Gibco. Grand Island. NY. USA) supplemented wxith Hepes (10 msm final concentration). L-glutamine (2 m\t final concentration). penicillin (100 U ml-'). streptomycmn (100 !g ml-) and 10%1 fetal calf serum (FCS) (Seromed. Berlin. Germany). Aliquots of 1 ml were distributed into 24-wxell plates (Costar. Cambridoe. MA. USA).
Stimulation of cytokine secretion was performed as presiously described Elsasser-Beile et al. 1991 : Fischer et al. 1995 (IL-1I3). 20-1000 pg ml (IL-2). 0.5-10 U ml-' (IFN-a). 10-1000 p ml-IFN-y) and 10-1000 pg ml-' (TNF-a). For each determination. SNs from duplicate wells were prepared.
Statistical analysis
The sianificance of differences between the results in the patient group and control subjects was calculated by usinc the Wilcoxon rank-sum test. the Kruskal-Wallis test and the Mann-Whitney rank-sum test.
RESULTS

Cytokine secretion in whole blood cell cultures of normal individuals
We first established the normal range of cytokine production in WBCCs in a group of -4 healthy adults according to previously established protocols (Fischer et al. 1995) . The secretion profiles for IFN-a. IFN-y. IL-la. IL-15. IL-2 and TNF-a are shown in Table 1 . Others have pointed out a potential decrease in cytokine levels with an increase in age (Elsasser-Beile et al. 1993a ). However. when we insestigated the cytokine secretion in this group we did not find any age-dependent variations (Fischer et al. 1995) . This excludes that differences in the capacity to secrete cytokines simply reflect differences of age.
Cytokine levels in patients with colorectal carcinoma are selectively reduced Having established the concentration in the control group. we compared the capacity of WBCCs from colorectal cancer patients to secrete these cytokines. The concentrations of TNF-a and IL-1 in the cancer patient group did not differ significantly from control subjects. Interestingly. patients with early stages of colorectal carcinoma had significantly enhanced TNF-a levels (Table 1 ). In Figure IA) . A similar tendency. although less pronounced. was seen for IL-la secretion ( Figure 1B) (1998) 78(8), [1018] [1019] [1020] [1021] [1022] [1023] The levels of IFN-ca IFN-y. IL-la and IL-2 were significantly reduced in WBCCs of patients as compared with the control population. In a previous report we investigated cytokine secretion in lung cancer patients. In WBCCs of small-cell lunc cancer and nonsmall-cell lung cancer patients secretion of IL-1 a was not reduced (Fischer et al. 1995) . In contrast. WBCCs of patients suffering, from bladder carcinoma contained significantly less TNF-a than WBCCs of control subjects (Elsasser-Beile et al. 1993b (Bang and Laing. 1986) . and reduced lymphocyte counts were associated with the appearance of colorectal polyps (Robins et al. 1991 ). There are reports that tumour cells secrete soluble factors that induce apoptosis in the T-cell population (Billings et al. 1997 FasLinduced apoptosis (Hahne et al. 1996) . Normal colonic cells do not express FasL. In contrast. FasL mRNA and protein were detected in some primary and in all of the investigated metastatic colorectal tumours (Shiraki et al. 1997 (Fischer et al. 1994) . Human colorectal carcinoma cells also frequently produce TGF-1I (Lahm and Odartchenko. 1993) .
which is an effective and selective suppressor of cvtokine secretion by peripheral lymphocstes (Fischer et al. 1995) . Furthermore. secretion of IL-10. another potent inhibitor of cytokine secretion. was found to be highest and most common in cell lines derived from colorectal carcinomas (GastI et al. 1993) . Animals treated with IL-10 showed a reduced expression of several cvtokines. including IFN-y. IL-1 and IL-2 (Herfarth et al. 1996) 
